Researchers develop dual-targeting drug for EBV-related cancers
Vitamin D supplementation and testing in the UK: costly but ineffective?
2 March 2021Kidney-on-a-chip offers clues to prevent kidney damage from essential drugs
2 March 2021Researchers develop dual-targeting drug for EBV-related cancers
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV).
